1. Ingrezza is a medication that is commonly prescribed to patients with ALS (Amyotrophic Lateral Sclerosis) to help manage symptoms such as involuntary movements.
2. Ingrezza works by targeting a specific neurotransmitter in the brain called dopamine, which is responsible for controlling movement.
3. One of the main benefits of Ingrezza is that it can help reduce the frequency and severity of involuntary movements, also known as dyskinesia, in patients with ALS.
4. Ingrezza is typically taken once daily, with or without food, as directed by a healthcare provider.
5. Common side effects of Ingrezza may include drowsiness, dry mouth, and headache. It is important to speak with your healthcare provider if you experience any side effects while taking Ingrezza.
6. Before starting Ingrezza, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have.
7. Ingrezza is not recommended for use in patients with severe liver impairment, as it may worsen liver function.
8. Ingrezza may interact with other medications, so it is important to discuss all of your current medications with your healthcare provider before starting Ingrezza.
9. It is important to follow your healthcare provider's instructions for taking Ingrezza, as well as attending regular follow-up appointments to monitor your progress and adjust your treatment plan as needed.
10. Ingrezza can be an effective treatment option for managing symptoms of ALS, but it is important to work closely with your healthcare provider to determine if it is the right choice for you.